Stem cells show mixed results in MI patients.
Kahn
Jason
J
Cardiovascular Research Foundation, New York, New York 10022-1122, USA. jkahn@crf.org
D000071916:AC133 Antigen; D015703:Antigens, CD / Q000008:administration & dosage; D019917:Blood Vessel Prosthesis Implantation; D002986:Clinical Trials as Topic; D020099:Coated Materials, Biocompatible / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D023903:Coronary Restenosis / Q000209:etiology / Q000517:prevention & control; D016207:Cytokines / Q000627:therapeutic use; D006023:Glycoproteins / Q000008:administration & dosage; D006329:Heart Conduction System / Q000503:physiopathology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology / Q000601:surgery*; D010455:Peptides / Q000008:administration & dosage; D015607:Stents; D013318:Stroke Volume; D016277:Ventricular Function, Left
D000071916:AC133 Antigen; D015703:Antigens, CD; D020099:Coated Materials, Biocompatible; D016207:Cytokines; D006023:Glycoproteins; D010455:Peptides